February 15, 2024 Pioneering the Future of Digital Pathology: Colorado State University and Visiopharm Launch Graduate Course

Veterinary pathologists Brendan Podell and Mac Harris will teach a MIP700 Topics course this coming fall semester focused on digital pathology, a cutting-edge frontier for veterinary pathology.
May 18, 2021 Researchers develop new way to evaluate tuberculosis treatments

A collaborative study, including the CSU Mycobacteria Research Laboratories, provides an important new basis for comparing the effectiveness of different tuberculosis treatments and accelerating the development of shorter regimens.
September 21, 2020 CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

An interdisciplinary CSU team is advancing a COVID-19 vaccine candidate with additional NIH support, that relies on riboflavin and UV light technology to create inactivated virus.
November 13, 2019 CSU lands $1.2 million in NIH funding to advance work on a new tuberculosis vaccine

Associate professors Marcela Henao Tamayo and Brendan Podell will lead an interdisciplinary team from the CSU Mycobacteria Research Laboratories to progress a vaccine for tuberculosis.
January 17, 2018 Pathologist studies intersection of tuberculosis and diabetes

Name the 2017 Zoetis Research Excellence Award recipient, Dr. Brendan Podell reflects on his academic and research path that led to his ongoing investigation of tuberculosis and diabetes.
April 9, 2015 Team lands NIH funds to examine tuberculosis and metabolism

Continuing their discoveries on the relationship between tuberculosis and metabolism, the CSU team will test new strategies for treatment of tuberculosis.